Docetaxel

Red

Brand Name(s):Toxetere

Indication:Hormone refractory prostate cancer

Rationale:1,2.3,8

Considered:Oct-06

Review Date:Sep-21

Comments:
Docetaxel is recommended, within its licensed indications, as a treatment option for men with hormone-refractory metastatic prostate cancer only if their Karnofsky performance-status score is 60% or more.

NICE TA 101
Docetaxel for the treatment of hormone-refractory metastatic prostate cancer June 2006